Poor Response to Checkpoint Immunotherapy in Uveal Melanoma Highlights the Persistent Need for Innovative Regional Therapy Approaches to Manage Liver Metastases

Poor Response to Checkpoint Immunotherapy in Uveal Melanoma Highlights the Persistent Need for Innovative Regional Therapy Approaches to Manage Liver Metastases

Uveal melanoma is a cancer that develops from melanocytes in the posterior uveal tract. Metastatic uveal melanoma is an extremely rare disease that has a poor long-term prognosis, limited treatment options and a strong predilection for liver metastasis. Median overall survival has been reported to b...

Full description

Bibliographic Details
Main Authors: Brett M. Szeligo, Abby D. Ivey, Brian A. Boone
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
uveal melanoma
isolated hepatic perfusion
percutaneous hepatic perfusion
immunotherapy
melphalan
Online Access:https://www.mdpi.com/2072-6694/13/14/3426

Similar Items

Similar Items